Transformative Teva chief Hurvitz dies at 79; India's new drug pricing to cost industry $286M, report says;

@FiercePharma: Forget DTC ads. Pfizer's going for direct-to-consumer sales: Lipitor from $PFE to people at generic price - WSJ. Story |  Follow @FiercePharma

> Eli Hurvitz, who led Teva Pharmaceutical Industries ($TEVA) through a period of aggressive expansion until his retirement last year, died at the age of 79 in Israel. News

> Teva Pharmaceutical Industries' newly acquired unit Cephalon has sued Impax Laboratories for patent infringement related to its pain drug Fentora. Story

> India's new drug pricing policy will cost drugmakers about $286 million, a study by pharma market researchers at AWACS has found. News

> Psoriasis drug sales in 7 major markets will mushroom to more than $7.4 billion in 2020 from $3.9 billion in 2010, Decision Resources finds. Item

> South Africa's Adcock Ingram reported a 19% increase in full-year profits to $90.6 million as demand for its consumer drugs increased. Piece

> Daiichi Sankyo launched Sevikar HCT, the U.K.'s first three-in-one combination pill for high blood pressure. Article

> AstraZeneca ($AZN) has rearranged its Americas management team, making Rich Fante regional VP and Marion McCourt COO of the U.S. business. News

> Cancer patients are living 6 times longer today than 40 years ago, but results vary widely according to cancer type. Item

Biotech News

@FierceBiotech: Perceptive Informatics survey focuses on role of imaging in clinical trials. News | Follow @FierceBiotech

@JohnCFierce:  Analysts inevitably buzzing about the next big hep C buyout. Story  | Follow @JohnCFierce

@RyanMFierce: NYT essay on overuse of word #cancer in medicine. "The word "cancer" is so powerful it overwhelms any conversation." Report | Follow @RyanMFierce

@MaureenFierce: Combo vaccines more convenient for children and parents, but might be costing doctors money. Item | Follow @MaureenFierce

> Pfizer adds to fibrosis drug pipeline with Excaliard buyout. Story

Biotech Research News

> Treatment for aggressive form of prostate cancer may be on horizon. Item

> Two old drugs eyed as new brain tumor treatment. News

> AvidBiotics' protein treatment could fight food-borne bacteria, study shows. Story

> Novartis to test malaria drug in 2012 that could defeat the virus more quickly. Report

> Discovery: Sugar plus two drugs may equal cancer cell suicide. Article

Manufacturing News

> Counterculture drugmaker spoofs Big Pharma. News

> Compounder questions KV's Makena purity claim. Item

> Ben Venue shutdown strains J&J drug supply. Report

> Thanks for a miracle in Congress. Story

> Bill cites fakes dangers, ups penalties. Article

> J&J yields to activists on baby-product chemicals. News

And Finally... Should thyroid drugs be used more often in patients with mood problems? Report

Suggested Articles

Gilead Sciences has found a new chief financial officer in an appointment that has mergers and acquisitions written all over it.

Pfizer's role as the hero in ramping up production of a chemo drug badly needed by pediatric oncologists is a turnabout for the drugmaker.

Johnson & Johnson is dealing with $2 billion in patent losses in 2019, but has 10 drugs growing at double-digit percentages, executives said Tuesday.